Page last updated: 2024-08-07 16:16:30

Cyclin-dependent kinase 2

A cyclin-dependent kinase 2 that is encoded in the genome of human. [PRO:DNx]

Synonyms

EC 2.7.11.22;
Cell division protein kinase 2;
p33 protein kinase

Research

Bioassay Publications (263)

TimeframeStudies on this Protein(%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (0.38)18.2507
2000's106 (40.30)29.6817
2010's122 (46.39)24.3611
2020's34 (12.93)2.80

Compounds (377)

Drugs with Inhibition Measurements

DrugTaxonomyMeasurementAverage (mM)Bioassay(s)Publication(s)
1-anilino-8-naphthalenesulfonateHomo sapiens (human)IC5091.000022
tyrphostin a23Homo sapiens (human)Ki0.616611
aristolochic acid iHomo sapiens (human)IC5020.000011
bisindolylmaleimide iHomo sapiens (human)IC5012.270025
bisindolylmaleimide ivHomo sapiens (human)IC5012.297524
bohemineHomo sapiens (human)IC501.366723
n(6),n(6)-dimethyladenineHomo sapiens (human)Ki1.096511
gw8510Homo sapiens (human)IC500.007977
indirubin-3'-monoximeHomo sapiens (human)IC500.576733
indirubin-5-sulfonateHomo sapiens (human)IC504.543649
staurosporine aglyconeHomo sapiens (human)IC500.943333
nsc 664704Homo sapiens (human)IC500.730022
methazolamideHomo sapiens (human)IC500.014011
nu2058Homo sapiens (human)IC5014.500068
nu2058Homo sapiens (human)Ki8.440045
nu6102Homo sapiens (human)IC502.09641927
nu6102Homo sapiens (human)Ki0.003522
o(6)-benzylguanineHomo sapiens (human)IC5029.500024
olomoucineHomo sapiens (human)IC5049.78612023
pd 153035Homo sapiens (human)IC50250.000011
1-NA-PP1Homo sapiens (human)IC509.007522
imatinibHomo sapiens (human)IC5050.9480714
whi p180Homo sapiens (human)IC501.000011
dichlororibofuranosylbenzimidazoleHomo sapiens (human)Ki65.000011
indazolesHomo sapiens (human)IC50185.000044
isocorydineHomo sapiens (human)IC5050.000011
corydineHomo sapiens (human)IC5050.000011
indirubinHomo sapiens (human)IC503.24001010
indigoHomo sapiens (human)IC5035.500022
canadineHomo sapiens (human)IC5050.000011
staurosporineHomo sapiens (human)IC501.62003131
staurosporineHomo sapiens (human)Ki0.002623
o-(6)-methylguanineHomo sapiens (human)IC50100.000011
7-hydroxystaurosporineHomo sapiens (human)Ki0.062512
fascaplysineHomo sapiens (human)IC50375.000044
LSM-4272Homo sapiens (human)IC5025.175012
5-Chloro-1H-indole-2,3-dioneHomo sapiens (human)IC501,000.000011
dehydroabietic acidHomo sapiens (human)IC5036.290011
o(6)-n-butylguanineHomo sapiens (human)IC5042.666723
2-(4-hydroxyphenyl)-5,6,7,8-tetrahydroxy-4H-1-benzopyran-4-oneHomo sapiens (human)IC50150.000012
aristolactam iHomo sapiens (human)IC501.200011
dicentrineHomo sapiens (human)IC5050.000011
aristolochic acid iiHomo sapiens (human)IC5020.000011
cercosporamideHomo sapiens (human)IC500.770011
3',4'-dihydroxyflavoneHomo sapiens (human)IC50500.000011
3,3',4'-trihydroxyflavoneHomo sapiens (human)IC504.000011
birb 796Homo sapiens (human)IC5030.000022
cyc 202Homo sapiens (human)IC502.48495766
cyc 202Homo sapiens (human)Ki0.250011
corytuberineHomo sapiens (human)IC5050.000011
stephanineHomo sapiens (human)IC5050.000011
aristolochic acid DHomo sapiens (human)IC5025.000011
aristolochic acid cHomo sapiens (human)IC5030.000011
sb 216763Homo sapiens (human)IC500.269011
erlotinibHomo sapiens (human)IC501.140011
2,4-diamino-6-benzyloxy-5-nitrosopyrimidineHomo sapiens (human)IC5027.000023
lapatinibHomo sapiens (human)IC5015.500022
sorafenibHomo sapiens (human)IC50150.000011
n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamideHomo sapiens (human)IC500.007011
paulloneHomo sapiens (human)IC502.700011
nu 6027Homo sapiens (human)IC502.375068
nu 6027Homo sapiens (human)Ki1.600034
2H-pyrazolo[4,3-b]quinoxalin-3-amineHomo sapiens (human)IC502.805022
pd 173955Homo sapiens (human)IC500.028011
n-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)ureaHomo sapiens (human)IC50100.000022
7-n-butyl-6-(4'-hydroxyphenyl)-5h-pyrrolo(2,3b)pyrazineHomo sapiens (human)IC500.260022
6-bromoindirubin-3'-oximeHomo sapiens (human)IC500.041522
purvalanol bHomo sapiens (human)IC500.007255
repsoxHomo sapiens (human)IC50100.000011
purvalanol aHomo sapiens (human)IC500.06171316
2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dioneHomo sapiens (human)IC5080.000033
cgp 60474Homo sapiens (human)IC500.004133
2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-1-benzopyran-4-oneHomo sapiens (human)IC50500.000011
N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-1-naphthalenecarboxamideHomo sapiens (human)IC5010.000011
cgp 74514aHomo sapiens (human)IC500.029733
1,4-dimethoxy-10H-acridine-9-thioneHomo sapiens (human)IC5035.050034
bms 387032Homo sapiens (human)IC503.23981515
bms 387032Homo sapiens (human)Ki0.038011
sf 2370Homo sapiens (human)IC500.145012
vx-745Homo sapiens (human)IC505.000011
dasatinibHomo sapiens (human)IC505.000022
sb 218078Homo sapiens (human)IC500.633323
7-butyl-6-(4-methoxyphenyl)-5H-pyrrolo[2,3-b]pyrazineHomo sapiens (human)Ki0.000511
sb 415286Homo sapiens (human)IC500.380011
alsterpaulloneHomo sapiens (human)IC500.015022
1-tert-butyl-3-naphthalen-1-ylmethyl-1h-pyrazolo(3,4-d)pyrimidin-4-ylemineHomo sapiens (human)IC5014.502522
quercetinHomo sapiens (human)IC5040.000011
luteolinHomo sapiens (human)IC5020.000011
harmineHomo sapiens (human)IC5025.000033
fisetinHomo sapiens (human)IC505.000011
wogoninHomo sapiens (human)IC501.460022
ellagic acidHomo sapiens (human)IC503.390011
alvocidibHomo sapiens (human)IC508.08823542
alvocidibHomo sapiens (human)Ki0.140033
aftin-4Homo sapiens (human)IC50556.666716
su 9516Homo sapiens (human)IC503.273369
casein kinase iiHomo sapiens (human)IC502.380011
arcyriaflavin aHomo sapiens (human)IC501.7677917
su 11248Homo sapiens (human)IC50130.000011
pd 0183812Homo sapiens (human)IC506.792736
palbociclibHomo sapiens (human)IC505.84361415
palbociclibHomo sapiens (human)Ki5.000011
jnj-7706621Homo sapiens (human)IC5027.6823416
salutaridineHomo sapiens (human)IC5050.000011
sinomenineHomo sapiens (human)IC5050.000011
olomoucine iiHomo sapiens (human)IC500.050011
2-tert-butyl-9-fluoro-3,6-dihydro-7h-benz(h)imidazo(4,5-f)isoquinoline-7-oneHomo sapiens (human)IC503.300011
vx680Homo sapiens (human)IC501.9978119
cyc 116Homo sapiens (human)IC501.220024
cyc 116Homo sapiens (human)Ki0.390022
gw2974Homo sapiens (human)IC508.000011
2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]ethanolHomo sapiens (human)IC508.466723
cvt 313Homo sapiens (human)IC500.198022
((3z)-n-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1h-pyrrol-2-yl)methylene)-n-methyl-2-oxo-2,3-dihydro-1h-indole-5-sulfonamide)Homo sapiens (human)Ki0.489811
jnj 10198409Homo sapiens (human)IC5010.000022
gw843682xHomo sapiens (human)IC507.600010
tofacitinibHomo sapiens (human)IC5010.000022
ap23464Homo sapiens (human)IC5013.933523
ly2090314Homo sapiens (human)IC502.800011
leucettamine bHomo sapiens (human)IC5010.000011
azd2858Homo sapiens (human)Ki0.540011
nu 6140Homo sapiens (human)IC50136.166733
sotrastaurinHomo sapiens (human)IC502.300011
saracatinibHomo sapiens (human)IC5010.000011
aristolactam aiiiaHomo sapiens (human)IC500.140022
meridianin aHomo sapiens (human)IC503.100011
l 783277Homo sapiens (human)IC5010.000011
rgb 286638Homo sapiens (human)IC500.002522
at 7519Homo sapiens (human)IC500.05861011
at 7519Homo sapiens (human)Ki0.277022
compound 26Homo sapiens (human)IC5010.000011
danusertibHomo sapiens (human)IC500.462011
N-[5-[[5-[(4-acetyl-1-piperazinyl)-oxomethyl]-4-methoxy-2-methylphenyl]thio]-2-thiazolyl]-4-[(3,3-dimethylbutan-2-ylamino)methyl]benzamideHomo sapiens (human)IC5029.000011
nvp-aew541Homo sapiens (human)IC5010.000011
5-(5,6-dimethoxy-1-benzimidazolyl)-3-[(2-methylsulfonylphenyl)methoxy]-2-thiophenecarbonitrileHomo sapiens (human)IC5030.000011
4-[2-(2-chloro-4-fluoroanilino)-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamideHomo sapiens (human)Ki0.528225
cgp 57380Homo sapiens (human)Ki10.000011
pha 767491Homo sapiens (human)IC500.240011
5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4h-1-benzopyran-4-oneHomo sapiens (human)IC507.300033
azd 1152-hqpaHomo sapiens (human)Ki10.000011
2-({2-[(3-hydroxyphenyl)amino]pyrimidin-4-yl}amino)benzamideHomo sapiens (human)IC502.700011
gsk 269962aHomo sapiens (human)IC503.500011
sb 772077-bHomo sapiens (human)IC507.000011
mk-8776Homo sapiens (human)IC500.160011
pha 848125Homo sapiens (human)IC500.2563913
14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaeneHomo sapiens (human)IC500.028266
azd5438Homo sapiens (human)IC500.015844
p276-00Homo sapiens (human)IC501.854733
meriolin 3Homo sapiens (human)IC500.011033
cx 4945Homo sapiens (human)IC501.800011
bms 754807Homo sapiens (human)IC501.035011
pci 32765Homo sapiens (human)IC5025.000011
cink4Homo sapiens (human)IC5028.800044
N-cyclopropyl-3-{4-[(cyclopropylmethyl)carbamoyl]phenyl}-4-methylbenzamideHomo sapiens (human)IC5020.000011
quizartinibHomo sapiens (human)IC5020.000022
defactinibHomo sapiens (human)IC500.344010
bs 194Homo sapiens (human)IC500.003033
entrectinibHomo sapiens (human)IC501.000011
(R)-DRF053Homo sapiens (human)IC500.191522
N-(2-chlorophenyl)-4-[[2-[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]anilino]-5-fluoro-4-pyrimidinyl]amino]benzamideHomo sapiens (human)IC5016.000011
4-[6-[4-(methoxycarbonylamino)phenyl]-4-(4-morpholinyl)-1-pyrazolo[3,4-d]pyrimidinyl]-1-piperidinecarboxylic acid methyl esterHomo sapiens (human)IC5050.000011
nms p715Homo sapiens (human)IC5055.000022
ribociclibHomo sapiens (human)IC5036.571477
bay 1000394Homo sapiens (human)IC500.008677
pha 793887Homo sapiens (human)IC500.008022
tak-632Homo sapiens (human)IC500.580011
sb 1518Homo sapiens (human)IC503.900011
abemaciclibHomo sapiens (human)IC500.263588
abemaciclibHomo sapiens (human)Ki0.504011
dinaciclibHomo sapiens (human)IC500.00742020
nms p937Homo sapiens (human)IC5010.000022
gilteritinibHomo sapiens (human)Ki1.485011
longdaysinHomo sapiens (human)IC5013.000011
nms-p118Homo sapiens (human)IC5010.000011
bs-181Homo sapiens (human)IC501.193333
butyrolactone iHomo sapiens (human)IC501.500022
lfm a13Homo sapiens (human)IC50500.000011
urmc-099Homo sapiens (human)IC501.180011
on123300Homo sapiens (human)IC500.197033
ceritinibHomo sapiens (human)IC503.970011
amg 925Homo sapiens (human)IC500.375011
ldc4297Homo sapiens (human)IC500.006411
THZ531Homo sapiens (human)IC501.300011
r 1530Homo sapiens (human)IC501.330011
can 508Homo sapiens (human)IC5024.8412817
can 508Homo sapiens (human)Ki41.150022
((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one)Homo sapiens (human)IC5020.000022
ro 3306Homo sapiens (human)IC500.219522
ro 3306Homo sapiens (human)Ki0.340011
hymenialdisineHomo sapiens (human)IC500.055022
nintedanibHomo sapiens (human)IC505.500022
debromohymenialdisineHomo sapiens (human)IC508.666117
nms-e973Homo sapiens (human)IC500.010011

Drugs with Activation Measurements

DrugTaxonomyMeasurementAverage (mM)Bioassay(s)Publication(s)
1-anilino-8-naphthalenesulfonateHomo sapiens (human)Kd37.000033
fasudilHomo sapiens (human)Kd30.000011
4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazolineHomo sapiens (human)Kd30.000011
nu6102Homo sapiens (human)Kd1.310011
sb 202190Homo sapiens (human)Kd10.000011
imatinibHomo sapiens (human)Kd16.666733
pyrazolanthroneHomo sapiens (human)Kd3.200011
rheinHomo sapiens (human)Kd9.600011
triciribine phosphateHomo sapiens (human)Kd30.000011
staurosporineHomo sapiens (human)Kd0.007433
picropodophyllinHomo sapiens (human)Kd30.000011
gefitinibHomo sapiens (human)Kd16.666733
lestaurtinibHomo sapiens (human)Kd0.123333
methotrexateHomo sapiens (human)EC500.001011
perifosineHomo sapiens (human)Kd30.000011
vatalanibHomo sapiens (human)Kd16.666733
ruboxistaurinHomo sapiens (human)Kd16.666733
canertinibHomo sapiens (human)Kd16.666733
birb 796Homo sapiens (human)Kd10.000022
cyc 202Homo sapiens (human)EC500.151011
cyc 202Homo sapiens (human)Kd12.100033
sb 203580Homo sapiens (human)Kd10.000022
enzastaurinHomo sapiens (human)Kd17.500022
erlotinibHomo sapiens (human)Kd16.666733
lapatinibHomo sapiens (human)Kd16.666733
sorafenibHomo sapiens (human)Kd14.675044
pd 173955Homo sapiens (human)Kd10.000011
s 1033Homo sapiens (human)Kd20.000022
xl147Homo sapiens (human)Kd30.000011
bms 387032Homo sapiens (human)Kd0.114333
sf 2370Homo sapiens (human)Kd0.101011
tandutinibHomo sapiens (human)Kd15.000044
vx-745Homo sapiens (human)Kd10.000022
dasatinibHomo sapiens (human)Kd16.666733
ha 1100Homo sapiens (human)Kd30.000011
7-epi-hydroxystaurosporineHomo sapiens (human)Kd30.000011
zd 6474Homo sapiens (human)Kd16.666733
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamideHomo sapiens (human)Kd10.000011
imd 0354Homo sapiens (human)Kd30.000011
buteinHomo sapiens (human)Kd100.000011
sirolimusHomo sapiens (human)Kd30.000011
alvocidibHomo sapiens (human)Kd0.659244
bosutinibHomo sapiens (human)Kd20.000022
orantinibHomo sapiens (human)Kd30.000011
su 11248Homo sapiens (human)Kd14.000055
palbociclibHomo sapiens (human)Kd30.000011
jnj-7706621Homo sapiens (human)Kd0.023011
vx680Homo sapiens (human)Kd16.666733
cyc 116Homo sapiens (human)Kd4.232011
everolimusHomo sapiens (human)Kd30.000011
ekb 569Homo sapiens (human)Kd20.000022
axitinibHomo sapiens (human)Kd20.000022
temsirolimusHomo sapiens (human)Kd30.000011
pd 184352Homo sapiens (human)Kd10.000011
on 01910Homo sapiens (human)Kd30.000011
av 412Homo sapiens (human)Kd30.000011
telatinibHomo sapiens (human)Kd30.000011
y-39983Homo sapiens (human)Kd30.000011
cp 547632Homo sapiens (human)Kd30.000011
bms345541Homo sapiens (human)Kd10.000011
lenvatinibHomo sapiens (human)Kd30.000011
pd 0325901Homo sapiens (human)Kd30.000011
midostaurinHomo sapiens (human)Kd15.000044
px-866Homo sapiens (human)Kd30.000011
ripasudilHomo sapiens (human)Kd30.000011
osi 930Homo sapiens (human)Kd30.000011
ki 20227Homo sapiens (human)Kd10.000011
scio-469Homo sapiens (human)Kd30.000011
cp 724714Homo sapiens (human)Kd20.000022
pi103Homo sapiens (human)Kd10.000022
hmn-214Homo sapiens (human)Kd30.000011
tivozanibHomo sapiens (human)Kd30.000011
hki 272Homo sapiens (human)Kd20.000022
tofacitinibHomo sapiens (human)Kd16.666733
n-(6-chloro-7-methoxy-9h-beta-carbolin-8-yl)-2-methylnicotinamideHomo sapiens (human)Kd10.000011
cediranibHomo sapiens (human)Kd20.000022
masitinibHomo sapiens (human)Kd20.000022
ly-2157299Homo sapiens (human)Kd30.000011
pazopanibHomo sapiens (human)Kd16.666733
azd 6244Homo sapiens (human)Kd20.000022
su 14813Homo sapiens (human)Kd16.666733
bibw 2992Homo sapiens (human)Kd20.000022
pik 75Homo sapiens (human)Kd0.540011
binimetinibHomo sapiens (human)Kd30.000011
sotrastaurinHomo sapiens (human)Kd30.000011
aee 788Homo sapiens (human)Kd30.000011
saracatinibHomo sapiens (human)Kd30.000011
vx 702Homo sapiens (human)Kd30.000011
crenolanibHomo sapiens (human)Kd0.128011
tg100-115Homo sapiens (human)Kd23.333323
cc 401Homo sapiens (human)Kd30.000011
bms 599626Homo sapiens (human)Kd30.000011
exel-7647Homo sapiens (human)Kd30.000011
volasertibHomo sapiens (human)Kd30.000011
pha 665752Homo sapiens (human)Kd10.000011
azd 7762Homo sapiens (human)Kd30.000011
regorafenibHomo sapiens (human)Kd30.000011
6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)-4-pyrimidinyl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-oneHomo sapiens (human)Kd20.000022
brivanibHomo sapiens (human)Kd20.000022
mp470Homo sapiens (human)Kd30.000011
rgb 286638Homo sapiens (human)Kd0.072011
np 031112Homo sapiens (human)Kd30.000011
at 7519Homo sapiens (human)Kd0.099522
bms-690514Homo sapiens (human)Kd30.000011
bi 2536Homo sapiens (human)Kd20.000022
inno-406Homo sapiens (human)Kd30.000011
nvp-ast487Homo sapiens (human)Kd0.605022
kw 2449Homo sapiens (human)Kd20.000022
danusertibHomo sapiens (human)Kd30.000011
abt 869Homo sapiens (human)Kd16.666733
azd 8931Homo sapiens (human)Kd30.000011
arq 197Homo sapiens (human)Kd30.000011
azd 1152Homo sapiens (human)Kd30.000011
pf 00299804Homo sapiens (human)Kd30.000011
ridaforolimusHomo sapiens (human)Kd30.000011
ch 4987655Homo sapiens (human)Kd30.000011
6-(5-((cyclopropylamino)carbonyl)-3-fluoro-2-methylphenyl)-n-(2,2-dimethylprpyl)-3-pyridinecarboxamideHomo sapiens (human)Kd30.000011
cc-930Homo sapiens (human)Kd30.000011
gw 2580Homo sapiens (human)Kd10.000022
tak 285Homo sapiens (human)Kd30.000011
idelalisibHomo sapiens (human)Kd30.000011
crizotinibHomo sapiens (human)Kd20.000022
osi 906Homo sapiens (human)Kd30.000011
chir-265Homo sapiens (human)Kd16.666733
motesanibHomo sapiens (human)Kd16.666733
fostamatinibHomo sapiens (human)Kd30.000012
trametinibHomo sapiens (human)Kd30.000011
mln8054Homo sapiens (human)Kd16.666733
pf-562,271Homo sapiens (human)Kd1.073011
GDC-0879Homo sapiens (human)Kd10.000011
jnj-26483327Homo sapiens (human)Kd30.000011
ly2603618Homo sapiens (human)Kd30.000011
tg100801Homo sapiens (human)Kd30.000011
dactolisibHomo sapiens (human)Kd30.000011
bgt226Homo sapiens (human)Kd30.000011
gsk 461364Homo sapiens (human)Kd20.000022
azd 1152-hqpaHomo sapiens (human)Kd16.666733
nvp-tae684Homo sapiens (human)Kd5.200011
enmd 2076Homo sapiens (human)Kd30.000011
e 7050Homo sapiens (human)Kd30.000011
2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)-7-pyrido[2,3-d]pyrimidinoneHomo sapiens (human)Kd30.000011
tak-901Homo sapiens (human)Kd30.000012
gdc-0973Homo sapiens (human)Kd30.000011
buparlisibHomo sapiens (human)Kd30.000011
azd 1480Homo sapiens (human)Kd30.000011
azd8330Homo sapiens (human)Kd30.000011
pha 848125Homo sapiens (human)Kd0.739011
ro5126766Homo sapiens (human)Kd30.000011
fedratinibHomo sapiens (human)Kd20.000022
gsk690693Homo sapiens (human)Kd20.000022
14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaeneHomo sapiens (human)Kd0.243011
azd5438Homo sapiens (human)Kd0.721011
pf 04217903Homo sapiens (human)Kd30.000011
gdc 0941Homo sapiens (human)Kd20.000022
icotinibHomo sapiens (human)Kd30.000011
ph 797804Homo sapiens (human)Kd30.000011
kx-01Homo sapiens (human)Kd30.000011
plx 4720Homo sapiens (human)Kd10.000011
mk 5108Homo sapiens (human)Kd30.000011
cx 4945Homo sapiens (human)Kd1.688011
cudc 101Homo sapiens (human)Kd30.000011
arry-614Homo sapiens (human)Kd30.000011
tak 593Homo sapiens (human)Kd30.000011
mln 8237Homo sapiens (human)Kd30.000011
sgx 523Homo sapiens (human)Kd20.000022
bms 754807Homo sapiens (human)Kd30.000011
bms 777607Homo sapiens (human)Kd30.000011
sgi 1776Homo sapiens (human)Kd30.000011
pci 32765Homo sapiens (human)Kd30.000012
ponatinibHomo sapiens (human)Kd30.000011
amg 900Homo sapiens (human)Kd30.000012
mk-1775Homo sapiens (human)Kd30.000011
AMG-208Homo sapiens (human)Kd30.000011
quizartinibHomo sapiens (human)Kd16.666733
at13148Homo sapiens (human)Kd30.000012
tak 733Homo sapiens (human)Kd30.000011
mk 2206Homo sapiens (human)Kd30.000011
sns 314Homo sapiens (human)Kd30.000011
lucitanibHomo sapiens (human)Kd30.000011
pf-04691502Homo sapiens (human)Kd30.000011
n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamideHomo sapiens (human)Kd2.113011
dcc-2036Homo sapiens (human)Kd0.199011
cabozantinibHomo sapiens (human)Kd30.000011
defactinibHomo sapiens (human)Kd1.656011
ly2584702Homo sapiens (human)Kd30.000011
incb-018424Homo sapiens (human)Kd20.000022
poziotinibHomo sapiens (human)Kd30.000011
asp3026Homo sapiens (human)Kd30.000011
entrectinibHomo sapiens (human)Kd30.000011
pexidartinibHomo sapiens (human)Kd30.000011
TAK-580Homo sapiens (human)Kd30.000011
gsk 2126458Homo sapiens (human)Kd30.000011
emd1214063Homo sapiens (human)Kd30.000011
gsk 1838705aHomo sapiens (human)Kd10.000011
pf 3758309Homo sapiens (human)Kd30.000011
gdc 0980Homo sapiens (human)Kd30.000011
azd2014Homo sapiens (human)Kd30.000011
(5-(2,4-bis((3s)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanolHomo sapiens (human)Kd30.000012
plx4032Homo sapiens (human)Kd30.000011
gsk 1363089Homo sapiens (human)Kd20.000022
arry-334543Homo sapiens (human)Kd30.000011
kin-193Homo sapiens (human)Kd30.000011
mk 2461Homo sapiens (human)Kd30.000011
bay 869766Homo sapiens (human)Kd30.000011
as 703026Homo sapiens (human)Kd30.000011
baricitinibHomo sapiens (human)Kd30.000011
dabrafenibHomo sapiens (human)Kd0.019011
pki 587Homo sapiens (human)Kd30.000011
n-(3-fluoro-4-((1-methyl-6-(1h-pyrazol-4-yl)-1h-indazol-5 yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamideHomo sapiens (human)Kd30.000011
ribociclibHomo sapiens (human)Kd30.000011
mk-8033Homo sapiens (human)Kd30.000011
pha 793887Homo sapiens (human)Kd0.098011
sb 1518Homo sapiens (human)Kd30.000011
abemaciclibHomo sapiens (human)Kd10.487011
mk-8776Homo sapiens (human)Kd30.000011
afuresertibHomo sapiens (human)Kd30.000011
gsk 1070916Homo sapiens (human)Kd30.000011
jnj38877605Homo sapiens (human)Kd30.000011
dinaciclibHomo sapiens (human)Kd0.054222
gilteritinibHomo sapiens (human)Kd30.000011
alectinibHomo sapiens (human)Kd30.000011
glpg0634Homo sapiens (human)Kd30.000011
encorafenibHomo sapiens (human)Kd30.000012
bms-911543Homo sapiens (human)Kd30.000011
gsk2141795Homo sapiens (human)Kd30.000011
azd8186Homo sapiens (human)Kd30.000011
byl719Homo sapiens (human)Kd30.000011
cep-32496Homo sapiens (human)Kd30.000011
rociletinibHomo sapiens (human)Kd30.000011
ceritinibHomo sapiens (human)Kd30.000011
azd1208Homo sapiens (human)Kd30.000011
vx-509Homo sapiens (human)Kd30.000011
debio 1347Homo sapiens (human)Kd30.000011
volitinibHomo sapiens (human)Kd30.000011
osimertinibHomo sapiens (human)Kd30.000011
at 9283Homo sapiens (human)Kd30.000011
otssp167Homo sapiens (human)Kd0.091011
chir 258Homo sapiens (human)Kd16.666733
osi 027Homo sapiens (human)Kd30.000011
nintedanibHomo sapiens (human)Kd15.700022
bay 80-6946Homo sapiens (human)Kd30.000011
pp242Homo sapiens (human)Kd10.000011

Drugs with Other Measurements

DrugTaxonomyMeasurementAverage (mM)Bioassay(s)Publication(s)
olomoucineHomo sapiens (human)ID507.000011
cyc 202Homo sapiens (human)INH24.500011
purvalanol bHomo sapiens (human)ID500.007522
cgp 60474Homo sapiens (human)ID500.050011
alvocidibHomo sapiens (human)Cell cycle0.02101010
alvocidibHomo sapiens (human)ID500.100011
olomoucine iiHomo sapiens (human)INH11.400011

Enables

This protein enables 9 target(s):

TargetCategoryDefinition
magnesium ion bindingmolecular functionBinding to a magnesium (Mg) ion. [GOC:ai]
protein serine/threonine kinase activitymolecular functionCatalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. [GOC:bf, MetaCyc:PROTEIN-KINASE-RXN, PMID:2956925]
cyclin-dependent protein serine/threonine kinase activitymolecular functionCyclin-dependent catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. [GOC:pr, GOC:rn, PMID:7877684, PMID:9841670]
protein bindingmolecular functionBinding to a protein. [GOC:go_curators]
ATP bindingmolecular functionBinding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. [ISBN:0198506732]
protein domain specific bindingmolecular functionBinding to a specific domain of a protein. [GOC:go_curators]
cyclin bindingmolecular functionBinding to cyclins, proteins whose levels in a cell varies markedly during the cell cycle, rising steadily until mitosis, then falling abruptly to zero. As cyclins reach a threshold level, they are thought to drive cells into G2 phase and thus to mitosis. [GOC:ai]
cyclin-dependent protein kinase activitymolecular functionCyclin-dependent catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP. [GOC:pr]
protein serine kinase activitymolecular functionCatalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate. [RHEA:17989]

Located In

This protein is located in 13 target(s):

TargetCategoryDefinition
chromosome, telomeric regioncellular componentThe end of a linear chromosome, required for the integrity and maintenance of the end. A chromosome telomere usually includes a region of telomerase-encoded repeats the length of which rarely exceeds 20 bp each and that permits the formation of a telomeric loop (T-loop). The telomeric repeat region is usually preceded by a sub-telomeric region that is gene-poor but rich in repetitive elements. Some telomeres only consist of the latter part (for eg. D. melanogaster telomeres). [GOC:elh]
condensed chromosomecellular componentA highly compacted molecule of DNA and associated proteins resulting in a cytologically distinct structure. [GOC:elh]
X chromosomecellular componentThe sex chromosome present in both sexes of species in which the male is the heterogametic sex. Two copies of the X chromosome are present in each somatic cell of females and one copy is present in males. [GOC:mah, GOC:mr, ISBN:0582227089, PMID:20622855, Wikipedia:XY_sex-determination_system]
Y chromosomecellular componentThe sex chromosome present in males of species in which the male is the heterogametic sex; generally, the sex chromosome that pairs with the X chromosome in the heterogametic sex. The Y chromosome is absent from the cells of females and present in one copy in the somatic cells of males. [GOC:mah, GOC:mr, ISBN:0582227089, PMID:20622855, Wikipedia:XY_sex-determination_system]
male germ cell nucleuscellular componentThe nucleus of a male germ cell, a reproductive cell in males. [CL:0000015, GOC:hjd, GOC:mtg_sensu]
nucleuscellular componentA membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators]
nuclear envelopecellular componentThe double lipid bilayer enclosing the nucleus and separating its contents from the rest of the cytoplasm; includes the intermembrane space, a gap of width 20-40 nm (also called the perinuclear space). [ISBN:0198547684]
nucleoplasmcellular componentThat part of the nuclear content other than the chromosomes or the nucleolus. [GOC:ma, ISBN:0124325653]
cytoplasmcellular componentThe contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684]
endosomecellular componentA vacuole to which materials ingested by endocytosis are delivered. [ISBN:0198506732, PMID:19696797]
centrosomecellular componentA structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle. [GOC:mah, ISBN:0198547684]
cytosolcellular componentThe part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl]
Cajal bodycellular componentA class of nuclear body, first seen after silver staining by Ramon y Cajal in 1903, enriched in small nuclear ribonucleoproteins, and certain general RNA polymerase II transcription factors; ultrastructurally, they appear as a tangle of coiled, electron-dense threads roughly 0.5 micrometers in diameter; involved in aspects of snRNP biogenesis; the protein coilin serves as a marker for Cajal bodies. Some argue that Cajal bodies are the sites for preassembly of transcriptosomes, unitary particles involved in transcription and processing of RNA. [NIF_Subcellular:nlx_subcell_090901, PMID:10944589, PMID:11031238, PMID:7559785]

Active In

This protein is active in 2 target(s):

TargetCategoryDefinition
cytoplasmcellular componentThe contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684]
nucleuscellular componentA membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators]

Part Of

This protein is part of 6 target(s):

TargetCategoryDefinition
cyclin A1-CDK2 complexcellular componentA protein complex consisting of cyclin A1 and cyclin-dependent kinase 2 (CDK2). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner. [GOC:so, PMID:15935619]
cyclin A2-CDK2 complexcellular componentA protein complex consisting of cyclin A2 and cyclin-dependent kinase 2 (CDK2). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner. [GOC:so, PMID:15935619]
cyclin E1-CDK2 complexcellular componentA protein complex consisting of cyclin E1 and cyclin-dependent kinase 2 (CDK2). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner. [GOC:so, PMID:15935619]
cyclin E2-CDK2 complexcellular componentA protein complex consisting of cyclin E2 and cyclin-dependent kinase 2 (CDK2). Cyclins are characterized by periodicity in protein abundance throughout the cell cycle. Cyclin-dependent kinases represent a family of serine/threonine protein kinases that become active upon binding to a cyclin regulatory partner. [GOC:so, PMID:15935619]
cyclin-dependent protein kinase holoenzyme complexcellular componentCyclin-dependent protein kinases (CDKs) are enzyme complexes that contain a kinase catalytic subunit associated with a regulatory cyclin partner. [GOC:krc, PMID:11602261]
transcription regulator complexcellular componentA protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription. [GOC:jl]

Involved In

This protein is involved in 31 target(s):

TargetCategoryDefinition
G1/S transition of mitotic cell cyclebiological processThe mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated. [GOC:mtg_cell_cycle]
G2/M transition of mitotic cell cyclebiological processThe mitotic cell cycle transition by which a cell in G2 commits to M phase. The process begins when the kinase activity of M cyclin/CDK complex reaches a threshold high enough for the cell cycle to proceed. This is accomplished by activating a positive feedback loop that results in the accumulation of unphosphorylated and active M cyclin/CDK complex. [GOC:mtg_cell_cycle]
negative regulation of transcription by RNA polymerase IIbiological processAny process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. [GOC:go_curators, GOC:txnOH]
DNA replicationbiological processThe cellular metabolic process in which a cell duplicates one or more molecules of DNA. DNA replication begins when specific sequences, known as origins of replication, are recognized and bound by the origin recognition complex, and ends when the original DNA molecule has been completely duplicated and the copies topologically separated. The unit of replication usually corresponds to the genome of the cell, an organelle, or a virus. The template for replication can either be an existing DNA molecule or RNA. [GOC:mah]
DNA repairbiological processThe process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway. [PMID:11563486]
chromatin remodelingbiological processA dynamic process of chromatin reorganization resulting in changes to chromatin structure. These changes allow DNA metabolic processes such as transcriptional regulation, DNA recombination, DNA repair, and DNA replication. [GOC:jid, GOC:vw, PMID:12042764, PMID:12697820]
DNA-templated transcriptionbiological processThe synthesis of an RNA transcript from a DNA template. [GOC:jl, GOC:txnOH]
protein phosphorylationbiological processThe process of introducing a phosphate group on to a protein. [GOC:hb]
potassium ion transportbiological processThe directed movement of potassium ions (K+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. [GOC:ai]
centriole replicationbiological processThe cell cycle process in which a daughter centriole is formed perpendicular to an existing centriole. An immature centriole contains a ninefold radially symmetric array of single microtubules; mature centrioles consist of a radial array of nine microtubule triplets, doublets, or singlets depending upon the species and cell type. Duplicated centrioles also become the ciliary basal body in cells that form cilia during G0. [GOC:cilia, GOC:kmv, ISBN:0815316194, PMID:9889124]
Ras protein signal transductionbiological processAn intracellular signaling cassette in which a small monomeric GTPase of the Ras subfamily relays a signal. [GOC:bf]
regulation of mitotic cell cyclebiological processAny process that modulates the rate or extent of progress through the mitotic cell cycle. [GOC:dph, GOC:go_curators, GOC:tb]
positive regulation of cell population proliferationbiological processAny process that activates or increases the rate or extent of cell proliferation. [GOC:go_curators]
peptidyl-serine phosphorylationbiological processThe phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine. [RESID:AA0037]
positive regulation of heterochromatin formationbiological processAny process that activates or increases the frequency, rate or extent of heterochromatin formation. [GOC:mah]
mitotic G1 DNA damage checkpoint signalingbiological processA signal transduction process that contributes to a mitotic cell cycle G1/S transition DNA damage checkpoint. [GOC:mtg_cell_cycle]
positive regulation of DNA-templated DNA replication initiationbiological processAny process that activates or increases the frequency, rate or extent of initiation of DNA-dependent DNA replication. [GOC:mah]
telomere maintenance in response to DNA damagebiological processAny process that occur in response to the presence of critically short or damaged telomeres. [GOC:BHF, GOC:BHF_telomere, GOC:jbu, PMID:15279784]
post-translational protein modificationbiological processThe process of covalently altering one or more amino acids in a protein after the protein has been completely translated and released from the ribosome. [GOC:jsg]
positive regulation of DNA replicationbiological processAny process that activates or increases the frequency, rate or extent of DNA replication. [GOC:go_curators]
positive regulation of DNA-templated transcriptionbiological processAny process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. [GOC:go_curators, GOC:txnOH]
centrosome duplicationbiological processThe replication of a centrosome, a structure comprised of a pair of centrioles and peri-centriolar material from which a microtubule spindle apparatus is organized. [GOC:ai]
cell divisionbiological processThe process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells. [GOC:di, GOC:go_curators, GOC:pr]
meiotic cell cyclebiological processProgression through the phases of the meiotic cell cycle, in which canonically a cell replicates to produce four offspring with half the chromosomal content of the progenitor cell via two nuclear divisions. [GOC:ai]
cellular response to nitric oxidebiological processAny process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitric oxide stimulus. [GOC:mah, GOC:yaf]
cellular senescencebiological processA cell aging process stimulated in response to cellular stress, whereby normal cells lose the ability to divide through irreversible cell cycle arrest. [GOC:BHF, PMID:28682291]
regulation of anaphase-promoting complex-dependent catabolic processbiological processAny process that modulates the frequency, rate or extent of anaphase-promoting complex-dependent catabolic process. [GO_REF:0000058, GOC:TermGenie, PMID:10921876]
regulation of G2/M transition of mitotic cell cyclebiological processAny signaling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G2 phase to M phase of the mitotic cell cycle. [GOC:mtg_cell_cycle, PMID:17329565]
signal transductionbiological processThe cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell. [GOC:go_curators, GOC:mtg_signaling_feb11]
regulation of gene expressionbiological processAny process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). [GOC:txnOH-2018]
response to organic substancebiological processAny process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus. [GOC:sm, PMID:23356676]